Sirna Therapeutics, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 114
Rang # Quantité totale PI 11 418
Note d'activité PI 2,3/5.0    25
Rang # Activité PI 31 955
Parent Alnylam Pharmaceuticals, Inc.
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

77 0
6 0
30 0
1
 
Dernier brevet 2024 - Rna interference mediated inhibi...
Premier brevet 1994 - Regulatable nucleic acid therape...
Dernière marque 2004 -
Première marque 2004 -

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) ge...
2022 Invention Short interfering nucleic acid (sina) compositions. The present invention relates to compounds, ...
Invention Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic ...
Invention Low molecular weight cationic lipids for oligonucleotide delivery. The instant invention provides...
Invention Rna interference mediated inhibition of prolyl hydroxylase domain 2 (phd2) gene expression using ...
2021 Invention Rna interference mediated inhibition of gene expression using short interfering nucleic acids (si...
Invention Rna interference mediated inhibition of gene expression using chemically modified short interferi...
Invention Novel tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides....
2020 Invention Short interfering nucleic acid (sina) compositions. The present invention relates to compounds, c...
2019 Invention Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short inter...
Invention Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides. Discl...
2018 Invention Chemically modified multifunctional short interfering nucleic acid molecules that mediate rna int...
Invention Novel low molecular weight cationic lipids for oligonucleotide delivery. The instant invention p...
Invention Short interfering nucleic acid (sina) molecules containing a 2′ internucleoside linkage (3dt). Th...
2017 Invention Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleoti...
Invention Single-stranded rnai agents containing an internal, non-nucleic acid spacer. The instant disclosu...
Invention Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery. The in...
Invention Segmented micro rna mimetics. This invention relates generally to segmented oligonucleotides capa...
Invention Novel single chemical entities and methods for delivery of oligonucleotides. In an embodiment th...
2016 Invention Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" che...
2004 P/S Biological preparations for research and laboratory use, namely, preparations for the modulation ...